Benitec Biopharma Competitors and Similar CompaniesClear all

Resverlogix's competitors and similar companies include Lexicon Pharmaceuticals.
Resverlogix
Resverlogix
Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Founding Date
Founding Date
2001
Founding Date
1995
Type
Type
Public
Type
Public
Tags
Locations
Locations
Calgary, CA HQ
San Francisco, US
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Bernards, US
Birmingham, US
Boston, US
Charlotte, US
see more
Employees
Employees
19
Employees
20216% increase
Valuation ($)
Valuation ($)
12.9 m
Valuation ($)
737.4 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$49.8m (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$274k (FY, 2025)
Gross profit
Gross profit
$50k (FY, 2025)
Gross profit
$49.5m (FY, 2025)
Net income
Net income
($7.8m) (FY, 2025)
Net income
($50.3m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 10m
Total funding raised
$ 244.7m
For sources of this data, please see the company profile

View Company Profiles

Lexicon Pharmaceuticals
HQ
The Woodlands, US
Employees
202↑ 16% increase

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company